Change over period: —
NSE · BALAMINES
BALAJI AMINE
-26.0% from the 52-week high · +94.2% above the low
Balaji Amines Ltd. engages in the manufacture and sale of specialty chemicals, aliphatic amines, and derivatives. The company is headquartered in Secunderabad, Telangana and currently employs 1,111 full-time employees. The firm is running a five-star hotel in Solapur, Maharashtra, namely Balaji Sarovar Premiere. The company operates through three segments: Amines & Specialty Chemicals, Hotel Division and Other segments. Its amines products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), DIETHYLAMINE and TRIMETHYLAMINE. Its specialty chemicals include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and DIMETHYLFORMAMIDE (DMF). Its derivatives include Di-Methyl Acetamide (DMAC), Di-Ethyl Amine Hydrochloride (DMA HCL), Tri-Ethyl Amine Hydrochloride (TEA HCL), Di-Ethyl Amine Hydrochloride (DEA HCL) and Tri-Methyl Amine Hydrochloride (TMA HCL). Its pharma excipients include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
The short version. BALAJI AMINE reported revenue of ₹468 crore for Sep 2026, up 37.2% from a year earlier. Net profit was ₹67 crore (up 91.4% year on year). Return on equity was 8.6% in Mar 2026. Promoter holding was 54.56% in Sep 2026, up 0.86 points over 8 quarters.
1 · The price
How has the stock traded?
BALAJI AMINE trades 26.0% below its 52-week high and 94.2% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹468 cr.
Sep 2026 net profit of ₹67 cr.
4.3 pts higher than a year earlier.
Revenue compounded at -15.0% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 468 | 456 | 395 | 331 | 341 | 358 | 353 | 313 |
| Net profit | 67 | 75 | 65 | 31 | 35 | 38 | 40 | 33 |
| Net margin % | 14.4 | 16.4 | 16.4 | 9.3 | 10.1 | 10.6 | 11.5 | 10.6 |
| EPS (₹) | 20.76 | 23.13 | 19.99 | 9.49 | 10.67 | 11.73 | 12.48 | 10.24 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1425 | 1397 | 1642 | 2355 | 2320 | 1311 | 936 | 943 |
| Net profit | 169 | 158 | 205 | 326 | 368 | 238 | 105 | 117 |
| Net margin % | 11.9 | 11.3 | 12.5 | 13.8 | 15.9 | 18.2 | 11.2 | 12.4 |
| EPS (₹) | 52.21 | 48.73 | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 | 36.14 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 8.6% in Mar 2026; debt to equity is 0.07.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 8.6 | 8.6 | 11.9 | 20.9 |
| Return on capital % | 10.2 | 10.2 | 15.4 | 31.9 |
| EBITDA margin % | 20.2 | 18.6 | 21.1 | 26.3 |
| Net margin % | 11.6 | 11.0 | 12.3 | 13.7 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -15.0% | 2.0% |
| Profit CAGR | -19.6% | -6.6% |
4 · The owners
Who holds it, and are they adding?
Up 0.86 pts over 8 quarters.
Down 1.91 pts over 8 quarters.
Down 0.16 pts over 8 quarters.
+3 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.7 | 54.62 | 54.59 | 54.59 | 54.59 | 54.59 | 54.56 | 54.56 | +0.86 |
| FII | 5.16 | 5.08 | 5.0 | 4.52 | 3.3 | 2.98 | 3.17 | 3.25 | -1.91 |
| DII | 1.66 | 1.48 | 1.47 | 1.52 | 1.53 | 1.46 | 1.59 | 1.5 | -0.16 |
| Public | 39.48 | 38.82 | 38.95 | 39.37 | 40.58 | 40.97 | 40.69 | 40.7 | +1.22 |
Mutual fund holdings · Oct 2026
9 schemes hold this stock
6 the month before.
- Motilal Oswal Nifty Microcap 250 Index Fund0.24% of NAV
- Mirae Asset Nifty Total Market Index Fund0.01% of NAV
- Bandhan Nifty Total Market Index Fund0.01% of NAV
- Motilal Oswal BSE 1000 Index Fund0.01% of NAV
- Angel One Nifty Total Market ETF0.01% of NAV
- Groww Nifty Total Market Index Fund0.01% of NAV
- Angel One Nifty Total Market Index Fund0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for BALAJI AMINE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about BALAJI AMINE
What is the BALAJI AMINE share price?
BALAJI AMINE (BALAMINES) last closed at ₹1,882.00, down 0.85% on the day. Its 52-week range is ₹977.20 to ₹2,566.80.
What is the market cap of BALAJI AMINE?
BALAJI AMINE has a market capitalisation of about ₹6,153 crore. Its price-to-earnings ratio is 26.2.
How are BALAJI AMINE's latest results?
BALAJI AMINE reported revenue of ₹468 crore for Sep 2026, up 37.2% from a year earlier. Net profit was ₹67 crore (up 91.4% year on year). Return on equity was 8.6% in Mar 2026. Promoter holding was 54.56% in Sep 2026, up 0.86 points over 8 quarters.
Who owns BALAJI AMINE?
As of Sep 2026, shareholding was: Promoter 54.56%, FII 3.25%, DII 1.5%, Public 40.7%.
How many mutual funds hold BALAJI AMINE?
9 mutual fund schemes held BALAJI AMINE in October 2026. That compares with 6 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 03 Jul 2026 · Final Dividend - Rs. 11
- 01 Aug 2025 · Final Dividend - Rs. 11
- 04 Jul 2024 · Final Dividend - Rs. 11
- 03 Jul 2023 · Final Dividend - Rs. 10
- 21 Jun 2022 · Final Dividend - Rs. 6
- 29 Jul 2021 · Final Dividend - Rs. 4
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.